As President-elect Donald Trump's transition team vets candidates for key healthcare positions, pharmaceutical industry ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Private equity group CVC Capital ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

The president-elect is hoping to put Kennedy in charge of the agency that oversees everything from drug, vaccine, and food ...

President-elect Donald Trump has picked a prominent vaccine skeptic to lead the nation’s sprawling public health apparatus.

Robert F. Kennedy Jr. has been angling for a role in the Trump administration since he endorsed the president-elect in August ...